Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA: Sanofi slow to report adverse events
Fierce Pharma
Wednesday, February 23, 2011 - 11:29pm
tags:
FDA, adverse events, Sanofi
Abbott Wins Reversal of J&J’s $1.67 Billion Patent Victory
Bloomberg
Wednesday, February 23, 2011 - 10:56pm
tags:
JNJ, Humira, Abbott Laboratories
Pfizer’s Crizotinib Wipes Out Rare Lymphoma in Two Test Cases
Bloomberg
Wednesday, February 23, 2011 - 10:52pm
tags:
Pfizer, crizotinib, lymphoma
Exelixis: Going Where No Drug Has Gone Before
Seeking Alpha
Wednesday, February 23, 2011 - 10:47pm
tags:
Exelixis, cabozantinib, prostate cancer
Why AEterna Zentaris Still Retains 200% to 300% Upside Potential
Seeking Alpha
Wednesday, February 23, 2011 - 10:44pm
tags:
Aeterna Zentaris
Onyx reports bigger 4Q loss as research costs grow
Yahoo/AP
Wednesday, February 23, 2011 - 10:41pm
tags:
ONYX Pharmaceuticals, earnings
Gilead Gears Up to Fight Cancer
Motley Fool
Wednesday, February 23, 2011 - 10:30pm
tags:
Gilead Sciences, cancer
Prolor Biotech: Will Phase 2 Growth Hormone Results Bring Uptick?
Seeking Alpha
Wednesday, February 23, 2011 - 10:27pm
tags:
growth hormone, Prolor
FDA approves kidney disease label for Onglyza
Yahoo/AP
Wednesday, February 23, 2011 - 10:06pm
tags:
kidney disease, FDA, Onglyza
Is Clinical Data/Forest Labs Deal Bad for Biotech?
Seeking Alpha
Wednesday, February 23, 2011 - 9:55pm
tags:
Forest Labs, Clinical Data, M&A
Anthera Pharma 4Q loss widens on costs
Yahoo/AP
Wednesday, February 23, 2011 - 9:47pm
tags:
Anthera, earnings
Novartis Chairman Vasella Gets Criticized Over Pay
Pharmalot
Wednesday, February 23, 2011 - 8:58am
tags:
Novartis, Daniel Vasella, executive pay
M&A fills patent holes, fuels geographic expansion
Fierce Pharma
Wednesday, February 23, 2011 - 8:55am
tags:
M&A, patents, Kyowa Hakko Kirin, Prostrakan, Forest Labs, Clinical Data, Amoun
New Senate Legislation May Impede Voluntary Self-Enforcement by Companies Regulated by FDA
FDA Law Blog
Wednesday, February 23, 2011 - 8:21am
tags:
FDA, Senate, recalls
Roche’s ‘Brilliant Concept’ Fades Amid Doctor Disappointment
Bloomberg
Wednesday, February 23, 2011 - 8:15am
tags:
Roche, Avastin, cancer
Exelixis Q4 loss narrows to $17.9M
Yahoo/AP
Wednesday, February 23, 2011 - 8:06am
tags:
earnings, Exelixis
FDA Setbacks Make Vivus a Buying Opportunity
Seeking Alpha
Wednesday, February 23, 2011 - 8:02am
tags:
FDA, Vivus, Qnexa, obesity
Vertex cystic fibrosis drug meets study goals
Yahoo/AP
Wednesday, February 23, 2011 - 7:53am
tags:
Vertex Pharmaceuticals, cystic fibrosis, VX-770
Somaxon says it received new patents on insomnia drug Silenor that will last until July 2027
Yahoo/AP
Wednesday, February 23, 2011 - 7:52am
tags:
patents, Silenor, Somaxon, insomnia
Telik loses $9.8M in Q4, $24.7M for year
Bizjournals.com
Wednesday, February 23, 2011 - 7:48am
tags:
Telik, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.